Veterinary Medicines

EURICAN DA-L, liofilizzato e solvente per sospensione iniettabile per cani

Not authorised
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, Serogroup Canicola, serovar Canicola, Inactivated
  • Canine distemper virus, Live
  • Canine adenovirus 2, Live
Download as PDF

Product identification

Medicine name:
EURICAN DA-L, liofilizzato e solvente per sospensione iniettabile per cani
Active substance:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, Serogroup Canicola, serovar Canicola, Inactivated
  • Canine distemper virus, Live
  • Canine adenovirus 2, Live
Target species:
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, Serogroup Canicola, serovar Canicola, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Canine distemper virus, Live
    3.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine adenovirus 2, Live
    2.50
    log10 cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."